Coherus Oncology, Inc. (CHRS)
NASDAQ·Healthcare·Biotechnology
$1.40
-2.78%
Mkt Cap $175.05M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
Implied Upside
+330.0%
Consensus $6.02 vs current $1.40
NASDAQ·Healthcare·Biotechnology
$1.40
-2.78%
Mkt Cap $175.05M
No recent rating data.
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
+330.0%
Consensus $6.02 vs current $1.40